JG
MLAB icon

Joel Greenblatt’s Mesa Laboratories MLAB Stock Holding History

Joel Greenblatt’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,437
Closed -$452K – 1057
2018
Q3 		$452K Buy
2,437
+413
+20% +$83.1K 0.01% 752
2018
Q2 		$427K Buy
+2,024
New +$354K 0.01% 724

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Joel Greenblatt's MLAB Position: Q4 2018 in Review

Joel Greenblatt sold out of Mesa Laboratories (MLAB) in Q4 2018, closing a stake of 2,437 shares — an estimated $452K sold.

Joel Greenblatt first reported a position in MLAB in Q2 2018 and held it in 2 quarters. The position peaked at $452K in Q3 2018. 109 funds tracked by Wall St. Rank hold MLAB as of Q4 2018.

  • Joel Greenblatt reported no remaining Mesa Laboratories position as of Q4 2018 after selling out during the quarter.
  • Joel Greenblatt sold 2,437 Mesa Laboratories shares in Q4 2018, an estimated $452K.
  • Joel Greenblatt first reported a position in Mesa Laboratories in Q2 2018 and held it in 2 quarters.
  • Joel Greenblatt's Mesa Laboratories position peaked at $452K in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2018.

Based on Gotham Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.